Latest News for: bio

Edit

‘Gut’ your health: How Leucine Rich Bio uses microbiome science to personalise preventive healthcare

Your Story 24 Feb 2026
From at-home microbiome testing to personalised diets and drug discovery ambitions, Bengaluru-based deeptech startup Leucine Rich Bio is shifting healthcare from treatment to prevention ....
Edit

£6m support takes Cheshire bio company’s Series A round to £30m

The Business Desk 24 Feb 2026
This extends the company’s Series A round to £30m ... The funding from AMR Action Fund... To register for an account, click here or login below... Login ... .
Edit

Bio-Techne to Present at Upcoming Investor Conferences

PR Newswire 24 Feb 2026
24, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ ... A live webcast of the presentations can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https.//investors.bio-techne.com/ir-calendar.
Edit

Essity in EU flagship project PROTEUS to develop bio-based super absorbents from algae (Essity AB (publ))

Public Technologies 24 Feb 2026
... Bio-based Europe Joint Undertaking (CBE JU) and its members. The project pioneers the development of bio-based super absorbents derived from sustainably harvested brown macroalgae.
Edit

76% stronger than plastic: Agriculture waste turned into tough material for wind turbines

Interesting Engineering 24 Feb 2026
Researchers at the University of Oulu, Finland, have developed a new class of bio-based resins that mimic existing oil-based materials ... Notably, these new bio-based materials are designed for the circular economy. .
Edit

Consano Bio to Present at BIO Investment & Growth Summit 2026

Citizen Tribune 23 Feb 2026
23, 2026 /PRNewswire/ -- Consano Bio, a clinical-stage ...
Edit

Precise Bio Announces Successful Transplantation of Additional Patients in Ongoing Clinical

Caledonian Record 23 Feb 2026
Continued clinical progress follows regulatory authorization to advance study ....
Edit

Palisade Bio Reports Rapid Clinical, Histologic and New Mechanistic Colon Tissue RNA Sequencing Data Supporting ...

Nasdaq Globe Newswire 23 Feb 2026
Phase 1b translational data demonstrate localized ileocolonic target engagement, suppression of inflammatory and fibrotic gene programs, and early clinical response within seven days ... .
Edit

Material Event (Form 8-K) (Gossamer Bio Inc)

Public Technologies 23 Feb 2026
). The text version of this document is not available ... Gossamer Bio Inc.
×